Cowen and Company’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-171,536
| Closed | -$2.25K | – | 545 |
|
|
2024
Q3 | $2.25K | Hold |
171,536
| – | – | ﹤0.01% | 505 |
|
|
2024
Q2 | $7.22K | Sell |
171,536
-600
| -0.3% | -$25 | ﹤0.01% | 442 |
|
|
2024
Q1 | $8.95K | Sell |
172,136
-100
| -0.1% | -$5 | ﹤0.01% | 467 |
|
|
2023
Q4 | $8.61K | Buy |
172,236
+72,236
| +72% | +$3.61K | ﹤0.01% | 413 |
|
|
2023
Q3 | $22K | Sell |
100,000
-3,678
| -4% | -$809 | ﹤0.01% | 341 |
|
|
2023
Q2 | $13.5K | Sell |
103,678
-27,900
| -21% | -$3.63K | ﹤0.01% | 364 |
|
|
2023
Q1 | $5.39K | Buy |
131,578
+23,678
| +22% | +$971 | ﹤0.01% | 447 |
|
|
2022
Q4 | $5.4K | Sell |
107,900
-50,200
| -32% | -$2.51K | ﹤0.01% | 418 |
|
|
2022
Q3 | $9K | Buy |
158,100
+33,400
| +27% | +$1.9K | ﹤0.01% | 435 |
|
|
2022
Q2 | $11K | Buy |
124,700
+25,100
| +25% | +$2.21K | ﹤0.01% | 392 |
|
|
2022
Q1 | $36K | Buy |
+99,600
| New | +$36K | ﹤0.01% | 300 |
|